Defensive Scan

Scan

Defensive Scan

raw scan snapshot — prices as of scan date, not live 42 rows · screens, not recommendations superseded by2026-04-26-defensive-scanported fromresearch/classic/scans/_archive/2026-02-26-defensive-scan.mdscan slugdefensive-scansource typescan-archive

Defensive sector stabilized after Feb 22 mean-reversion — RSIs across the board now 46-73, most names sitting near SMA20. CLX still extended (RSI 72.6). GIS approaching oversold (RSI 30). HRL recovered sharply (RSI 52 from 38). No extreme readings; sector entering a neutral digest phase after the safety rotation.


Quick Snapshot

Signal Reading
Overall 🟡 NEUTRAL / DIGESTING — Defensive RSIs have compressed from Feb 16 extremes; most names near SMA20 and mid-range RSI. Rotation into defensives has stalled.
Most improved HRL ($25.35, RSI 52.5) — recovered from RSI 38 on 2/22, +3.3% 7D, now back above SMA20
Still extended CLX (RSI 72.6) — only name still in overbought territory
New oversold watch GIS (RSI 30.0, -3.6% below SMA20) — approaching oversold, but fundamental headwinds

Price Table (Validated 2026-02-26)

Stock Price 7D 30D RSI SMA20 vs SMA Status Action
JNJ $242.36 -1.3% +10.0% 60.4 $238.62 +1.6% 🟡 Neutral 🔒 Hold
KO $80.57 +2.1% +11.0% 61.5 $78.33 +2.9% 🟡 Neutral 🔒 Hold
PG $163.57 +3.2% +9.4% 61.7 $158.78 +3.0% 🟡 Neutral 🔒 Hold
CL $97.00 +3.2% +13.8% 58.6 $94.48 +2.7% 🟡 Neutral 🔒 Hold
CLX $127.14 +4.0% +13.9% 72.6 $121.09 +5.0% 🟠 Near Overbought ⚠️ Avoid
MCD $334.72 +2.3% +7.0% 66.8 $326.22 +2.6% 🟡 Neutral 🔒 Hold
GIS $44.85 +0.1% +0.5% 30.0 $46.51 -3.6% 🟢 Approaching Oversold 🔍 Watch
HRL $25.35 +3.3% +2.0% 52.5 $24.62 +3.0% 🟡 Neutral 🔍 Watch
MDLZ $59.99 +2.3% +2.5% 48.6 $60.00 -0.0% 🟡 Neutral 🔍 Watch
WMT $124.73 -0.1% +6.0% 46.6 $126.64 -1.5% 🟡 Neutral 🔍 Watch
COST $988.33 +0.1% +1.2% 49.7 $986.00 +0.2% 🟡 Neutral 🔍 Watch

Tier Analysis

Tier 1: Still Extended (RSI 67+) — Caution

CLX (RSI 72.6, +5.0% above SMA20, +13.9% 30D) Clorox is the only defensive name still running hot. +4.0% in 7 days and RSI climbing back toward Feb 16 highs. Consumer staples defensives rallying on macro uncertainty, but CLX at RSI 72.6 and 5% above SMA is not an entry. Thesis: household products demand is recession-resilient. Trim zone above RSI 75. Wait for $118-120 on a pullback (SMA retest).

MCD (RSI 66.8, +2.6% above SMA20, +7.0% 30D) McDonald's recovered from RSI 71 (2/22) and is now at 66.8 — cooling in the right direction. +2.3% 7D with solid trend momentum. RSI approaching neutral. Still 2.6% above SMA20. Not a buy here, but the cleanest mid-large defensive for a pullback watch at $320-322.

Tier 2: Neutral / Digest (RSI 47-62): Core Hold / Watch Zone

JNJ (RSI 60.4, +1.6% above SMA20) Johnson & Johnson has corrected well from RSI 75.6 (2/22) to 60.4. Now a clean hold — RSI mid-range, modest SMA premium. Pharma/medical devices thesis intact. If RSI pulls to 50-52, interesting add zone.

KO (RSI 61.5, +2.9% above SMA20) Coca-Cola continuing its run — +2.1% 7D, RSI held at 61.5 (down from 72 on 2/22). Beverage pricing power intact. Similar to JNJ: good hold, not a new entry yet. Watch for RSI < 50 entry.

PG (RSI 61.7, +3.0% above SMA20) Procter & Gamble up +3.2% 7D — consumer staples catching a bid. RSI 61.7 recovered from 71 peak. Household staples thesis. Hold zone.

CL (RSI 58.6, +2.7% above SMA20) Colgate-Palmolive continuing to build from the RSI 70 correction. +3.2% 7D, RSI 58.6. Nice decompression. Watch for entry zone near $93-94 (SMA20 retest) if RSI dips to 50.

WMT (RSI 46.6, -1.5% below SMA20) Walmart continues the post-correction drift. -0.1% 7D, essentially flat. RSI 46.6 is neutral-bearish. Still below SMA20 ($126.64). The -8.1% 7D drop from 2/22 found a base around $122-124. Retail dominance thesis intact. Entry zone: $120-122, RSI < 42.

COST (RSI 49.7, +0.2% above SMA20) Costco is the cleanest defensive with the least drama. +0.1% 7D, RSI 49.7, sitting right at SMA20. +1.2% 30D — minimal movement either way. Best quality/risk-reward in the group if consumer spending holds. Entry zone: $960-975, RSI < 45.

MDLZ (RSI 48.6, flat vs SMA20) Mondelez recovered from the Feb 22 SMA breakdown. Now sitting right at SMA20 ($59.99 vs SMA $60.00 — essentially on the line). RSI 48.6 neutral. The relative weakness vs peers (only +2.5% 30D when others ran +10-14%) is still present. Watch — not a buy yet.

HRL (RSI 52.5, +3.0% above SMA20) Hormel had a strong recovery — from RSI 38 (2/22) to RSI 52.5 today, +3.3% 7D. Now back above SMA20. Fundamental headwinds (turkey commodity exposure, margin pressure) haven't changed, but the RSI signal improved meaningfully. No longer flagged as weak. Neutral watch.

Tier 3: Approaching Oversold — Monitor Closely

GIS (RSI 30.0, -3.6% below SMA20, +0.5% 30D) General Mills is now the most interesting name in the defensive scan — RSI 30.0, exactly at the oversold threshold. -3.6% below SMA20. Only +0.5% in 30 days when the rest of the defensive group ran +7-14%. This relative underperformance is a yellow flag. GIS faces headwinds from private-label competition and volume deceleration. RSI < 30 would trigger a watch signal, but fundamental weakness makes this low conviction. Wait for RSI < 25 with a reversal candle before acting.


Entry Zones

Stock Entry Zone RSI Trigger Conviction Notes
COST $960-$975 RSI < 45 MEDIUM-HIGH Best quality defensive; cleanest SMA setup
WMT $118-$122 RSI < 42 MEDIUM Retail dominance intact; needs RSI confirmation
CL $92-$94 RSI < 50 MEDIUM SMA20 retest entry on continued cooling
GIS $43-$44 RSI < 25 LOW Approaching oversold but relative weakness persists
JNJ $232-$237 RSI < 50 MEDIUM Pharma/MedDevice; RSI cooling toward entry
CLX $118-$121 RSI < 55 LOW-MEDIUM Wait for full SMA retest; currently 5% above SMA

Action Matrix

Action Stocks Why
⚠️ AVOID CLX RSI 72.6, 5% above SMA, still extended
🔒 HOLD JNJ, KO, PG, CL, MCD RSI 58-67, near SMA, thesis intact, healthy decompression
🔍 WATCH WMT, COST, MDLZ, GIS, HRL Mid-range RSI, near SMA, waiting for entry confirmation

vs Feb 22 Scan (What Changed)

Stock RSI 2/22 RSI 2/26 Delta Signal Change
JNJ 75.6 60.4 -15.2 🟠→🟡 Full neutral — corrected well
KO 72.0 61.5 -10.5 🟠→🟡 Cooling, still slightly elevated
PG 71.1 61.7 -9.4 🟠→🟡 Cooling, still slightly elevated
CL 69.9 58.6 -11.3 🟡→🟡 Healthy compression, nearing entry range
CLX 74.9 72.6 -2.3 🟠→🟠 Barely moved — still extended
MCD 71.0 66.8 -4.2 🟠→🟡 Slow cooling, still above neutral
GIS 72.3 30.0 -42.3 🟠→🟢 MASSIVE drop — biggest swing in group
HRL 38.0 52.5 +14.5 🟢→🟡 Recovered from oversold
MDLZ 51.7 48.6 -3.1 🔴→🟡 Recovered back to SMA20
WMT 55.2 46.6 -8.6 🟡→🟡 Continued drift, now below SMA
COST 63.1 49.7 -13.4 🟡→🟡 Healthy compression, at SMA

The Gold

Key Discoveries

Discovery Implication
GIS RSI crashed from 72.3 to 30.0 in 4 days -42 point RSI drop in 4 days is extreme — General Mills hit by something specific (earnings miss? volume deceleration data?)
HRL RSI recovered from 38 to 52.5 in 4 days Chronic underperformer bouncing — but thesis hasn't changed; treat as a dead-cat until further data
CLX barely cooled (74.9→72.6) while all others compressed Clorox specifically attracting defensive buying — possibly a safety/staples rotation play in uncertain macro
MDLZ recovered from SMA breakdown back to SMA neutral The Feb 22 breakdown was temporary; now at exactly SMA20 — direction of next move is the tell
WMT still -1.5% below SMA despite being -8.1% 7D just 4 days ago The WMT dip found a floor — further downside limited, but not yet a compelling buy

Mistakes (Don't Repeat)

Mistake Lesson
Watching GIS at RSI 72 without noting it as a trim zone RSI 72 was already extended on 2/22; should have flagged as avoid then
Treating HRL RSI 38 as a buy signal on 2/22 RSI 38 can always go lower when fundamentals are weak — needed a reversal confirmation

Open Questions

  • What specific catalyst drove GIS RSI from 72 to 30 in 4 days? Earnings guidance, volume data?
  • Is CLX's refusal to cool (RSI barely changed) a sign of true demand or trapped buyers?
  • WMT: is the -8.1% 7D from Feb 22 now fully absorbed, or is there more downside to SMA?
  • When defensive RSIs normalize to 50-55, will capital rotate back to growth (NVDA, AMZN)?
10 events

No direct external sources are attached to this read.